https://www.selleckchem.com/pr....oducts/pf-03084014-p
COVID-19 has decreased colorectal cancer screenings. To estimate the degree to which expanding fecal immunochemical test-based colorectal cancer screening participation during the COVID-19 pandemic is associated with clinical outcomes. A previously developed simulation model was adopted to estimate how much COVID-19 may have contributed to colorectal cancer outcomes. The model included the US population estimated to have completed colorectal cancer screening pre-COVID-19 according the American Cancer Society. The model wa
Like
Comment
Share
